Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simon L. Ruskin was a New York-based physician and prolific pharmaceutical chemist who operated primarily through the Physiological Chemicals Company and Ruskin Laboratories during the mid-20th century. He is best known for his pioneering research into the stabilization and therapeutic use of Vitamin C (ascorbic acid) and the development of various metal-salt complexes of antibiotics, such as penicillin. His work resulted in hundreds of patents covering a wide range of medicinal chemistry applications, including treatments for respiratory conditions, nutritional supplements, and hormonal therapies. The entity was instrumental in the early commercialization of stabilized vitamins and improved antibiotic formulations. Although the company is no longer active, Ruskin's innovations significantly influenced the development of modern pharmaceutical manufacturing and drug delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Simon L. Ruskin.